K. Dahlman-ghozlan et al., Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate0.05% cream: A retrospective clinical and histopathologic study, J AM ACAD D, 40(3), 1999, pp. 451-457
Background: Treatment with clobetasol propionate 0.05% cream is effective a
gainst lichen sclerosus et atrophicus (LSA) of the vulva.
Objective: The purpose of this study was to retrospectively evaluate whethe
r clinical and histologic responses to topical clobetasol can be accomplish
ed in penile LSA.
Methods: A self-assessment questionnaire was obtained from 22 men with LSA,
and a clinical examination was performed in 21 of them. Biopsy specimens f
rom 15 cases were compared before and after treatment.
Results: Itching, burning, pain, dyspareunia, phimosis, and dysuria decreas
ed significantly (P <.001 to .05) after 1 to 2 daily applications, for a me
an of 7.1 weeks (2-16 weeks). Additional operation for phimosis was require
d in 6 of the 22 men. All histologic LSA criteria were significantly (P <.0
1 to .05) reduced after treatment.
Conclusion: Topical treatment of penile LSA with clobetasol propionate repr
esents a safe and effective therapy with no risk of epidermal atrophy but w
ith some potential for triggering latent infections, most importantly human
papillomavirus.